During the past decade, Direct Helpers Research Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 15 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Direct Helpers Research Center" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Arbor Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Direct Helpers Research Center" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Takeda Development Center Americas, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Direct Helpers Research Center" are "Atopic Dermatitis" (4 trials), "Ulcerative Colitis" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Cardiovascular Disease" (2 trials) and "Acute Migraine With or Without Aura" (1 trials). Many other conditions were trialed in "Direct Helpers Research Center" in a lesser frequency.

Most popular intervention types in "Direct Helpers Research Center" are "Drug" (24 trials), "Other" (7 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Lebrikizumab" (4 trials), "AVP-786" (2 trials), "Mirikizumab" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Direct Helpers Research Center" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Direct Helpers Research Center". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Direct Helpers Research Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Direct Helpers Research Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".